While millions of Americans watched their team advance in the World Cup this week, some investors enjoyed cheering in another way. Three health-care stocks, in particular, experienced huge victories over the past few days.
One of this week's big winners announced positive results from a mid-stage study of its lead drug. Another reported great news from two late-stage studies of a drug combo. And the best-performing health-care stock of all benefited from an unexpected buyout offer from its largest customer.
Which health-care stocks soared stupendously this week? Find out by watching the slideshow below.
Leaked: This coming device has every company salivating
The best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.
Keith Speights has no position in any stocks mentioned. The Motley Fool recommends Vertex Pharmaceuticals. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.